Filter
1725
Text search:
pharmaceutical
services
Featured
Recommendations
156
New Publications
440
Language
Document type
No document type
869
Studies & Reports
352
Guidelines
256
Strategic & Response Plan
88
Manuals
87
Fact sheets
23
Training Material
19
Situation Updates
12
Resource Platforms
9
Infographics
5
Brochures
4
Online Courses
1
Countries / Regions
Kenya
77
Ethiopia
72
Global
71
India
65
South Africa
48
Nigeria
42
Uganda
37
Western and Central Europe
37
Sierra Leone
32
Liberia
32
Namibia
32
Ghana
27
Tanzania
26
Rwanda
25
Nepal
24
Zambia
24
Ukraine
24
Africa
23
Bangladesh
20
Malawi
20
Philippines
18
Eastern Europe
18
Latin America and the Carribbean
16
Syria
15
Zimbabwe
14
Indonesia
14
Lesotho
13
Cambodia
12
Eswatini/ Swaziland
12
Myanmar / Burma
11
Congo, Democratic Republic of
9
Botswana
9
West and Central Africa
9
South–East Asia Region
9
Asia
9
Eastern Europe and Central Asia
7
Senegal
6
Cameroon
6
Thailand
6
Benin
6
Guinea
5
Burkina Faso
5
Haiti
5
South Sudan
5
East and Southern Africa
5
Albania
5
Pakistan
4
Mozambique
4
Papua New Guinea
4
Western Pacific Region
4
Venezuela
4
Laos
4
Vietnam
4
Mali
3
Jordan
3
Afghanistan
3
Germany
3
China
3
Sudan
3
Brazil
3
North Macedonia
3
Middle East and North Africa
3
Russia
3
North America
3
United Kingdom
3
USA
2
Iraq
2
Central African Republic
2
Fiji
2
Tajikistan
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Niger
1
Somalia
1
Lebanon
1
Egypt
1
Chad
1
Malaysia
1
Ireland
1
Peru
1
Serbia
1
Ecuador
1
El Salvador
1
Libya
1
Angola
1
Madagascar
1
Sri Lanka
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
748
Clinical Guidelines
105
Key Resources
81
Public Health
74
Women & Child Health
39
Pharmacy & Technologies
27
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
AMR
164
Pharmacy
149
COVID-19
130
Mental Health
99
HIV
96
TB
78
NTDs
51
NCDs
36
Planetary Health
35
Caregiver
34
Conflict
32
Global Health Education
32
Rapid Response
30
Health Financing Toolbox
28
Ebola & Marburg
26
Malaria
20
2.0 Rapid Response
14
Disability
13
Refugee
11
Specific Hazards
9
Natural Hazards
8
Polio
7
Cholera
4
Zika
3
Social Ethics
1
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
The vision of the new Strategic Action Plan for Strengthening HIS in Myanmar 2017- 2021 is “A strong health information system for a strong health system”. The mission statement of HIS in Myanmar also developed during the strategic planning exercise is “Generating and making accessible compreh
...
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community phar
...
Phytochem Rev (2023) 22:1691–1806
Plants have a lot of potential and will continue to contribute feasible, effective medicines and/or pesticides; more research is warranted to fully explore their future applications
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Towards a Healthier Botswana
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep
...
AMR is a serious and growing global problem. A WHO report released in 2014 stated that this serious threat is no longer a prediction for the future it is happening now in every region of the world and has potential to affect anyone, of any age in any community – a real threat to the public health.
...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande
...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding
...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi
...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u
...
